References
Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of TLS. Am J Med. 2004;116:546–54.
Del Toro G, Morris E, Cairo MS. TLS: pathophysiology, definition, and alternative treatment approaches. Clin Adv Hematol Oncol. 2005;3:54–61.
Kalemkerian GP, Darwish B, Varterasian ML. TLS in small cell carcinoma and other solid tumors. Am J Med. 1997;103:363–7.
Burney IA. Acute TLS after transcatheter chemoembolization of hepatocellular carcinoma. South Med J. 1998;91:467–70.
Sakamoto N, Monzawa S, Nagano H, Nishizaki H, Arai Y, Sugimura K. Acute TLS caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2007;30:508–11.
Lehner SG, Gould JE, Saad WE, Brown DB. TLS after radio-frequency ablation of hepatocellular carcinoma. Am J Roentgenol. 2005;185:1307–9.
Lee CC, Wu YH, Chung SH, Chen WJ. Acute TLS after thalidomide therapy in advanced hepatocellular carcinoma. Oncologist. 2006;11:87–8.
Hsieh PM, Hung KC, Chen YS. TLS after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review. World J Gastroenterol. 2009;15(37):4726–8.
Shiba H, Ishida Y, Wakiyama S, Sakamoto T, Misawa T, Yanaga K. Acute TLS after transarterial chemoembolization for hepatocellular carcinoma. Cancer Sci. 2008;99(10):2104–5.
Cairo MS, Bishop M. TLS: new therapeutic strategies and classification. Br J Haematol. 2004;127:3–11.
Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg. 2006;202:155–68.
Nawawi O, Hazman M, Abdullah B, Vijayananthan A, Manikam J, Mahadeva S, Goh K. Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience. Biomed Imaging Interv J. 2010;6(1):e7.
Guiu B, Deschamps F, Aho S, Munck F, Dromain C, Boige V, Malka D, Leboulleux S, Ducreux M, Schlumberger M, Baudin E, de Baere T. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol. 2012;56(3):609–17.
Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int. 2004;24:210–5.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katiman, D., Manikam, J., Goh, KL. et al. Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma. J Gastrointest Canc 43 (Suppl 1), 187–190 (2012). https://doi.org/10.1007/s12029-012-9373-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-012-9373-6